YARON NAOS

Corporate Board Profile

Tech Score: 0/100

← Back to All Directors

Protalix BioTherapeutics, Inc.

Filing Date Source Excerpt
2018-10-17 Yaron Naos(6)
2019-10-15 Security Ownership of Certain Beneficial Owners and Management table
2021-09-30 Yaron Naos Consists of 19,955 outstanding shares of our common stock and 88,330 shares of our common stock issuable upon exercise of outstanding options

Data sourced from SEC filings. Last updated: 2026-02-08